Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Janux Therapeutics (JANX) Return on Assets (2021 - 2025)

Janux Therapeutics (JANX) has disclosed Return on Assets for 5 consecutive years, with 0.11% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Assets fell 3.0% to 0.11% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.11%, a 3.0% decrease, with the full-year FY2025 number at 0.11%, down 1.0% from a year prior.
  • Return on Assets was 0.11% for Q4 2025 at Janux Therapeutics, down from 0.1% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.05% in Q3 2021 to a low of 0.2% in Q2 2023.
  • A 5-year average of 0.12% and a median of 0.11% in 2025 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: decreased -11bps in 2022, then grew 13bps in 2024.
  • Janux Therapeutics' Return on Assets stood at 0.08% in 2021, then crashed by -101bps to 0.17% in 2022, then grew by 11bps to 0.15% in 2023, then soared by 48bps to 0.08% in 2024, then tumbled by -43bps to 0.11% in 2025.
  • Per Business Quant, the three most recent readings for JANX's Return on Assets are 0.11% (Q4 2025), 0.1% (Q3 2025), and 0.1% (Q2 2025).